ATI RN
ATI RN Exit Exam
1. A client with type 2 diabetes mellitus is scheduled for an arteriogram. Which of the following medications should the nurse instruct the client to discontinue 48 hours prior to the procedure?
- A. Atorvastatin
- B. Digoxin
- C. Nifedipine
- D. Metformin
Correct answer: D
Rationale: The correct answer is D, Metformin. Metformin should be discontinued 48 hours before an arteriogram due to the risk of lactic acidosis. Atorvastatin (Choice A) is a statin used to lower cholesterol levels and is not typically contraindicated before an arteriogram. Digoxin (Choice B) is a medication used for heart conditions and does not need to be discontinued before an arteriogram. Nifedipine (Choice C) is a calcium channel blocker used to treat high blood pressure and angina, and it is not necessary to discontinue before the procedure.
2. A client is receiving brachytherapy for the treatment of prostate cancer. Which of the following actions should the nurse take?
- A. Cleanse equipment before removal from the client's room
- B. Limit the client's visitors to 30 minutes per day
- C. Discard the client's linens in a double bag
- D. Discard the radioactive source in a biohazard bag
Correct answer: B
Rationale: The correct action the nurse should take when caring for a client receiving brachytherapy is to limit the client's visitors to 30 minutes per day. This is crucial to reduce exposure to radiation and maintain safety during the brachytherapy procedure. Cleansing equipment before removal from the client's room may be important for infection control but is not directly related to brachytherapy procedures. Discarding the client's linens in a double bag and discarding the radioactive source in a biohazard bag are incorrect choices as they do not specifically address the safety measures needed during brachytherapy for prostate cancer.
3. A healthcare professional is preparing to administer digoxin to a client with heart failure. Which of the following laboratory values should the professional report to the provider?
- A. Potassium 4.0 mEq/L
- B. Calcium 9.5 mg/dL
- C. Sodium 140 mEq/L
- D. Magnesium 2.0 mg/dL
Correct answer: C
Rationale: The correct answer is C: Sodium 140 mEq/L. An elevated sodium level can affect the effectiveness of digoxin therapy and may lead to toxicity. Therefore, it is crucial to report this value to the provider. Potassium, calcium, and magnesium levels are important as well, but elevated sodium can have a more direct impact on digoxin therapy in this scenario.
4. A client has a hemoglobin level of 7 g/dL. Which of the following findings should the nurse expect?
- A. Bounding pulses
- B. Elevated blood pressure
- C. Headache
- D. Pale, cool skin
Correct answer: D
Rationale: Pale, cool skin is a common finding in clients with a hemoglobin level of 7 g/dL due to decreased oxygen carrying capacity. Bounding pulses (Choice A) are not typically associated with low hemoglobin levels. Elevated blood pressure (Choice B) is not a common finding in clients with anemia. While headache (Choice C) can occur with anemia, it is not a specific finding directly related to a hemoglobin level of 7 g/dL.
5. A healthcare professional is caring for a client who has a new prescription for metformin. Which of the following laboratory results should the healthcare professional review before administering the medication?
- A. Potassium
- B. Serum creatinine
- C. Sodium
- D. Hemoglobin A1C
Correct answer: B
Rationale: Correct Answer: The healthcare professional should review serum creatinine levels before administering metformin to assess kidney function. Metformin is excreted by the kidneys, and checking serum creatinine helps prevent lactic acidosis, a potential side effect in individuals with impaired renal function. Choice A: Potassium levels are not directly related to the administration of metformin. While monitoring potassium levels is important for some medications, it is not the priority when initiating metformin. Choice C: Sodium levels are not typically assessed specifically before starting metformin. It is not a routine lab test required prior to metformin administration. Choice D: Hemoglobin A1C reflects long-term blood sugar control and is not a lab test that needs to be reviewed before initiating metformin. It is used to monitor diabetes management over time, not for immediate medication administration considerations.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access